INMB - INmune Bio GAAP EPS of -$0.43 November, 02 2022 04:57 PM INmune Bio Inc. INmune Bio press release ( NASDAQ: INMB ): Q3 GAAP EPS of -$0.43. As of September 30, 2022, the Company had cash and cash equivalents of approximately $57.4 million. For further details see: INmune Bio GAAP EPS of -$0.43